Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47.1M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
+16.8M
-
Total reported value, excl. options
-
$56.2M
-
Value change
-
+$29.1M
-
Put/Call ratio
-
0.81
-
Number of buys
-
21
-
Number of sells
-
-25
-
Price
-
$1.78
Significant Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q1 2025
60 filings reported holding WHWK - Whitehawk Therapeutics, Inc. - Common stock as of Q1 2025.
Whitehawk Therapeutics, Inc. - Common stock (WHWK) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 47.1M outstanding shares and own 67.47% of the company stock.
Largest 10 shareholders include QVT Financial LP (4.52M shares), ORBIMED ADVISORS LLC (4.17M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.7M shares), ACUTA CAPITAL PARTNERS, LLC (3.41M shares), Avoro Capital Advisors LLC (2.85M shares), Siren, L.L.C. (2.08M shares), EcoR1 Capital, LLC (2.08M shares), Yu Fan (2.07M shares), BML Capital Management, LLC (1.89M shares), and ACORN CAPITAL ADVISORS, LLC (1.14M shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.